PCI Pharma
PCI Pharma Services, a Philadelphia contract drug manufacturer, invested in a 200,000-square-foot manufacturing facility in Rockford. The site will enhance the company’s ability to create a variety of injectable biologic drugs, including those that treat diabetes, obesity, cancer and autoimmune disease, and also have product testing capabilities, on-site cold storage, and packaging and labeling machines.
Year Relocated: 2023
Amount in Capital Investment: $50,000,000
Year Relocated
2023
Number of Jobs
250
Capital Investment
$50,000,000